SEQ-9 | Interleukin Related interleukin-related.com

Product Name :
SEQ-9

Search keywords :
SEQ-9

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Ribosome inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sanofi

Active Company_Name :
Sanofi

Active Indication_Name:
Tuberculosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD31 (YP5047) Mouse mAb supplier
Cosibelimab Technical Information
FXR1 Antibody: FXR1 Antibody is an unconjugated, approximately 70 kDa, rabbit-derived, anti-FXR1 monoclonal antibody. FXR1 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts